Education (Colleges & Universities)
Here's a look at documents from public, private and community colleges in the U.S.
Education (Colleges & Universities)
Featured Stories
Yale School of Management: A Message From the Director of Admissions - What Happens After You Hit 'Submit'
NEW HAVEN, Connecticut, Nov. 17 -- Yale School of Management issued the following news:
* * *
A Message from the Director of Admissions: What Happens After You Hit 'Submit'
November 16, 2026
Keith Gallinelli offers a behind-the-scenes peek at the MBA for Executives admissions process.
It's been wonderful to engage with so many of you through our on-campus and virtual information sessions, events, and visits to your towns and cities. My admissions team and I have had the pleasure of communicating with many of you, via email, on the phone, online, or in person. I hope that you have found these ... Show Full Article NEW HAVEN, Connecticut, Nov. 17 -- Yale School of Management issued the following news: * * * A Message from the Director of Admissions: What Happens After You Hit 'Submit' November 16, 2026 Keith Gallinelli offers a behind-the-scenes peek at the MBA for Executives admissions process. It's been wonderful to engage with so many of you through our on-campus and virtual information sessions, events, and visits to your towns and cities. My admissions team and I have had the pleasure of communicating with many of you, via email, on the phone, online, or in person. I hope that you have found theseinteractions helpful and that you're now considering applying--or have already submitted an application in Round 1--for a spot in the Class of 2029. If you missed the deadline this time around, don't worry; we have two more application rounds and more opportunities to connect in the near future. Visit our events page for upcoming events.
If you've made it even partway through the application, allow me to congratulate you! The application process itself can be daunting. Starting it--and hopefully finishing it--is no small feat.
You may be curious about what happens after you hit the "submit" button. This part of the process might feel a little stressful and mysterious, but I hope the information below will help ease your anxiety about what's coming next.
While you may not hear much from us immediately after submitting your application, please know that the admissions committee begins reading each application carefully and thoroughly right away. One of the questions I hear most often is, "What exactly is the committee looking for?" While every application is evaluated holistically, there are a few themes we consistently look for: a clear sense of your leadership journey and how you've grown into roles of greater responsibility, a thoughtful articulation of why this is the right moment in your life and career for an MBA, and a well-rounded academic picture, including any relevant undergraduate or graduate coursework and test scores, that shows you're ready to take on our rigorous curriculum.
If you are invited to interview, you will come to campus to meet with the admissions staff and MBA for Executives alumni for individual interviews as well as a group discussion. You'll also have the opportunity to sit in on a live class during the interview day, giving you a real sense of what it's like to be a student in our program. The application timeline is a helpful reference as you plan for potential interview dates. Most candidates tell us that, while interview day can feel like a big commitment, it's also one of the most valuable parts of the process, offering a genuine look at the community you would be joining.
Once you schedule your interview, an employer approval form will be sent to the individual you identified in your application within 48 hours. Alongside the approval form, we also include the Class of 2029 academic calendar highlighting residency weeks, class weekends, and other important dates. It's a good idea to share this calendar with all your stakeholders, both personal and professional. Succeeding in this program is truly a team effort, so the sooner your support system understands what's ahead and is invested in your success, the better equipped you'll be to navigate it.
Following the interview days, the admissions committee will reconvene and release final decisions for that round. While each student admitted must complete an interview, not receiving an invitation to interview immediately after a round deadline does not necessarily mean you won't eventually be interviewed--and perhaps admitted--at some point during the application season.
Finally, if you haven't yet applied to the Yale MBA for Executives program and would like feedback on your candidacy, I encourage you to submit your resume or LinkedIn profile for pre-assessment. A member of our admissions team will personally review your profile and offer guidance on the next steps.
I hope that this peek into our process has been helpful. As always, if you have any questions, please don't hesitate to contact us.
* * *
Original text here: https://som.yale.edu/story/2026/message-director-admissions-what-happens-after-you-hit-submit
* * *
A Message from the Director of Admissions: What Happens After You Hit 'Submit'
November 16, 2026
Keith Gallinelli offers a behind-the-scenes peek at the MBA for Executives admissions process.
It's been wonderful to engage with so many of you through our on-campus and virtual information sessions, events, and visits to your towns and cities. My admissions team and I have had the pleasure of communicating with many of you, via email, on the phone, online, or in person. I hope that you have found these ... Show Full Article NEW HAVEN, Connecticut, Nov. 17 -- Yale School of Management issued the following news: * * * A Message from the Director of Admissions: What Happens After You Hit 'Submit' November 16, 2026 Keith Gallinelli offers a behind-the-scenes peek at the MBA for Executives admissions process. It's been wonderful to engage with so many of you through our on-campus and virtual information sessions, events, and visits to your towns and cities. My admissions team and I have had the pleasure of communicating with many of you, via email, on the phone, online, or in person. I hope that you have found theseinteractions helpful and that you're now considering applying--or have already submitted an application in Round 1--for a spot in the Class of 2029. If you missed the deadline this time around, don't worry; we have two more application rounds and more opportunities to connect in the near future. Visit our events page for upcoming events.
If you've made it even partway through the application, allow me to congratulate you! The application process itself can be daunting. Starting it--and hopefully finishing it--is no small feat.
You may be curious about what happens after you hit the "submit" button. This part of the process might feel a little stressful and mysterious, but I hope the information below will help ease your anxiety about what's coming next.
While you may not hear much from us immediately after submitting your application, please know that the admissions committee begins reading each application carefully and thoroughly right away. One of the questions I hear most often is, "What exactly is the committee looking for?" While every application is evaluated holistically, there are a few themes we consistently look for: a clear sense of your leadership journey and how you've grown into roles of greater responsibility, a thoughtful articulation of why this is the right moment in your life and career for an MBA, and a well-rounded academic picture, including any relevant undergraduate or graduate coursework and test scores, that shows you're ready to take on our rigorous curriculum.
If you are invited to interview, you will come to campus to meet with the admissions staff and MBA for Executives alumni for individual interviews as well as a group discussion. You'll also have the opportunity to sit in on a live class during the interview day, giving you a real sense of what it's like to be a student in our program. The application timeline is a helpful reference as you plan for potential interview dates. Most candidates tell us that, while interview day can feel like a big commitment, it's also one of the most valuable parts of the process, offering a genuine look at the community you would be joining.
Once you schedule your interview, an employer approval form will be sent to the individual you identified in your application within 48 hours. Alongside the approval form, we also include the Class of 2029 academic calendar highlighting residency weeks, class weekends, and other important dates. It's a good idea to share this calendar with all your stakeholders, both personal and professional. Succeeding in this program is truly a team effort, so the sooner your support system understands what's ahead and is invested in your success, the better equipped you'll be to navigate it.
Following the interview days, the admissions committee will reconvene and release final decisions for that round. While each student admitted must complete an interview, not receiving an invitation to interview immediately after a round deadline does not necessarily mean you won't eventually be interviewed--and perhaps admitted--at some point during the application season.
Finally, if you haven't yet applied to the Yale MBA for Executives program and would like feedback on your candidacy, I encourage you to submit your resume or LinkedIn profile for pre-assessment. A member of our admissions team will personally review your profile and offer guidance on the next steps.
I hope that this peek into our process has been helpful. As always, if you have any questions, please don't hesitate to contact us.
* * *
Original text here: https://som.yale.edu/story/2026/message-director-admissions-what-happens-after-you-hit-submit
Waynesburg U. Professor Davis Selected to Serve as 2030 Pittcon President
WAYNESBURG, Pennsylvania, Nov. 17 -- Waynesburg University issued the following news:
* * *
Waynesburg U. professor Davis selected to serve as 2030 Pittcon president
Nov 16, 2026
Dr. Bradley Davis, professor of chemistry at Waynesburg University, has been selected to serve as the 2030 president of Pittcon, an internationally renowned conference and exposition dedicated to laboratory science.
Pittcon, also known as the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, brings together scientists, researchers, industry professionals and educators from around the world to ... Show Full Article WAYNESBURG, Pennsylvania, Nov. 17 -- Waynesburg University issued the following news: * * * Waynesburg U. professor Davis selected to serve as 2030 Pittcon president Nov 16, 2026 Dr. Bradley Davis, professor of chemistry at Waynesburg University, has been selected to serve as the 2030 president of Pittcon, an internationally renowned conference and exposition dedicated to laboratory science. Pittcon, also known as the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, brings together scientists, researchers, industry professionals and educators from around the world toshare advancements in analytical research and instrumentation.
"Pittcon has been an important part of my professional development since my days as a student at Waynesburg, making the opportunity to serve as the 2030 president truly an honor," said Davis. "I've always admired the dedication of Pittcon's volunteers and staff to its mission of science education and outreach, and I am excited for the opportunity to continue working alongside them to advance that mission."
As part of Pittcon's standard selection process, conference presidents are named several years in advance to facilitate planning and preparation.
Davis has held numerous leadership positions within the organization, overseeing committees responsible for the conference's employment bureau, registration, technical program and contracts and negotiations. He served as conference treasurer last year and currently chairs the committee responsible for the exposition. Through these and other leadership roles within Pittcon's supporting society, Davis has served several terms on the organization's Board of Directors.
Davis first became involved with Pittcon and its founding societies as a student at Waynesburg under the mentorship of the late Dr. Robert LaCount, professor emeritus of chemistry. Throughout his career, LaCount encouraged student involvement in the organizations because of their service-oriented missions and the professional development opportunities they afforded students.
Continuing that tradition, Davis regularly engages Waynesburg students in Pittcon and its supporting society. Each year, he nominates students to serve as Student Aides, providing them with opportunities to volunteer at the conference while also participating in its technical program and exposition.
Davis earned his bachelor's degree from Waynesburg University and his doctorate in chemistry from Pennsylvania State University. At Waynesburg, he teaches courses in analytical chemistry and instrumental analysis, among others. His research focuses primarily on engaging students in the application of chromatography and spectroscopy to analytical chemistry.
Founded in 1950 by the Society for Analytical Chemists of Pittsburgh and the Spectroscopy Society of Pittsburgh, which recently merged, Pittcon was established to provide scientists with a forum to share research and developments in their respective fields. The conference has since evolved into an annual international event hosted in cities across the United States.
In 2027, Pittcon will return to Pittsburgh for the first time in 60 years. The conference will again be held in Pittsburgh in 2030 under Davis's leadership.
Beyond its role as a scientific conference, Pittcon is a nonprofit organization with a longstanding commitment to science education and outreach. Proceeds from its annual conference support regional and national programs, grants and awards that advance that mission.
For more information about Pittcon, visit pittcon.org.
* * *
About Waynesburg U.
Consistently ranked a best value school, Waynesburg University's Strategy for the 21st Century affirms its commitment to developing an entrepreneurial mindset and ethical leadership skills for all students. Rooted in its mission of faith, learning and service, the private, Christian university is located on a traditional campus in the hills of southwestern Pennsylvania.
* * *
Original text here: https://www.waynesburg.edu/news/waynesburg-u-professor-davis-selected-serve-2030-pittcon-president
* * *
Waynesburg U. professor Davis selected to serve as 2030 Pittcon president
Nov 16, 2026
Dr. Bradley Davis, professor of chemistry at Waynesburg University, has been selected to serve as the 2030 president of Pittcon, an internationally renowned conference and exposition dedicated to laboratory science.
Pittcon, also known as the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, brings together scientists, researchers, industry professionals and educators from around the world to ... Show Full Article WAYNESBURG, Pennsylvania, Nov. 17 -- Waynesburg University issued the following news: * * * Waynesburg U. professor Davis selected to serve as 2030 Pittcon president Nov 16, 2026 Dr. Bradley Davis, professor of chemistry at Waynesburg University, has been selected to serve as the 2030 president of Pittcon, an internationally renowned conference and exposition dedicated to laboratory science. Pittcon, also known as the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, brings together scientists, researchers, industry professionals and educators from around the world toshare advancements in analytical research and instrumentation.
"Pittcon has been an important part of my professional development since my days as a student at Waynesburg, making the opportunity to serve as the 2030 president truly an honor," said Davis. "I've always admired the dedication of Pittcon's volunteers and staff to its mission of science education and outreach, and I am excited for the opportunity to continue working alongside them to advance that mission."
As part of Pittcon's standard selection process, conference presidents are named several years in advance to facilitate planning and preparation.
Davis has held numerous leadership positions within the organization, overseeing committees responsible for the conference's employment bureau, registration, technical program and contracts and negotiations. He served as conference treasurer last year and currently chairs the committee responsible for the exposition. Through these and other leadership roles within Pittcon's supporting society, Davis has served several terms on the organization's Board of Directors.
Davis first became involved with Pittcon and its founding societies as a student at Waynesburg under the mentorship of the late Dr. Robert LaCount, professor emeritus of chemistry. Throughout his career, LaCount encouraged student involvement in the organizations because of their service-oriented missions and the professional development opportunities they afforded students.
Continuing that tradition, Davis regularly engages Waynesburg students in Pittcon and its supporting society. Each year, he nominates students to serve as Student Aides, providing them with opportunities to volunteer at the conference while also participating in its technical program and exposition.
Davis earned his bachelor's degree from Waynesburg University and his doctorate in chemistry from Pennsylvania State University. At Waynesburg, he teaches courses in analytical chemistry and instrumental analysis, among others. His research focuses primarily on engaging students in the application of chromatography and spectroscopy to analytical chemistry.
Founded in 1950 by the Society for Analytical Chemists of Pittsburgh and the Spectroscopy Society of Pittsburgh, which recently merged, Pittcon was established to provide scientists with a forum to share research and developments in their respective fields. The conference has since evolved into an annual international event hosted in cities across the United States.
In 2027, Pittcon will return to Pittsburgh for the first time in 60 years. The conference will again be held in Pittsburgh in 2030 under Davis's leadership.
Beyond its role as a scientific conference, Pittcon is a nonprofit organization with a longstanding commitment to science education and outreach. Proceeds from its annual conference support regional and national programs, grants and awards that advance that mission.
For more information about Pittcon, visit pittcon.org.
* * *
About Waynesburg U.
Consistently ranked a best value school, Waynesburg University's Strategy for the 21st Century affirms its commitment to developing an entrepreneurial mindset and ethical leadership skills for all students. Rooted in its mission of faith, learning and service, the private, Christian university is located on a traditional campus in the hills of southwestern Pennsylvania.
* * *
Original text here: https://www.waynesburg.edu/news/waynesburg-u-professor-davis-selected-serve-2030-pittcon-president
University of Indianapolis Board of Trustees Extend President Tanuja Singh's Contract Through 2031
INDIANAPOLIS, Indiana, Nov. 17 -- The University of Indianapolis issued the following news release:
* * *
University of Indianapolis Board of Trustees extend President Tanuja Singh's contract through 2031
November 16, 2026
The University of Indianapolis Board of Trustees unanimously approved a new five-year contract for President Tanuja Singh, extending her tenure through 2031. Singh, who became UIndy's 10th president in July 2023, had nearly two years remaining on her current contract.
"The Board of Trustees is extremely pleased to announce the early extension of Dr. Singh's contract," said ... Show Full Article INDIANAPOLIS, Indiana, Nov. 17 -- The University of Indianapolis issued the following news release: * * * University of Indianapolis Board of Trustees extend President Tanuja Singh's contract through 2031 November 16, 2026 The University of Indianapolis Board of Trustees unanimously approved a new five-year contract for President Tanuja Singh, extending her tenure through 2031. Singh, who became UIndy's 10th president in July 2023, had nearly two years remaining on her current contract. "The Board of Trustees is extremely pleased to announce the early extension of Dr. Singh's contract," saidBoard Chair Deborah Daniels. "President Singh has implemented a strategic response at UIndy to the significant challenges facing higher education institutions. Under her leadership, UIndy provides a cost-effective education that prepares its students for successful careers and community leadership. We are confident the university and its students will benefit greatly by her continued service."
"I am very grateful to the Board of Trustees for their continued trust and confidence in my leadership," said Singh. "Over the past three years, we have worked together as a University community to establish a clear vision for UIndy's future and take meaningful steps toward making it happen. I am proud of what we have already accomplished and even more excited about the future. We have an amazing opportunity to build on our momentum, expand our impact and ensure that the University of Indianapolis continues to be a place where students, faculty and staff thrive and are empowered to transform the world around them."
Singh has led a period of strategic growth and innovation at the University of Indianapolis. Among her accomplishments:
* Developed a new strategic plan for UIndy, approved in 2024 by the Board of Trustees, which established a renewed mission and vision for the institution.
* Established UIndy Online, which launched its first three undergraduate programs earlier this year to expand access to affordable and flexible education for nontraditional learners in areas of clear workforce need, including health sciences and elementary education.
* Expanded community partnerships, including an innovative collaboration with Perry Township Schools to bring high school students to the UIndy campus for entrepreneurship education and career-connected learning, as well as career-relevant experiential learning opportunities developed with corporate partners.
* Helped attract significant philanthropic support to strengthen programs across campus, including a $6 million gift to expand the Ron and Laura Strain Honors College, a $5 million gift to establish new programs and help first-generation students in the School of Business and a $2 million gift to establish the R.B. Annis Distinguished Professor of Engineering.
* Spearheaded the creation of the Women's Executive Leadership Institute to provide coaching and executive training to women aspiring to senior leadership roles within their organizations.
"President Singh has made a meaningful impact on our city and region by focusing UIndy's strategy, deepening community partnerships and enhancing outcomes for the university and for Indiana's workforce," said Matt Mindrum, president and CEO of the Indy Chamber. "I'm excited to see what comes next as President Singh continues to serve students and work with the business community to grow the Indy region's economy."
"President Tanuja Singh is an extraordinary leader whose impact reaches far beyond the University of Indianapolis and is helping shape the future of our entire community," said IBJ Media CEO Nate Feltman. "She has brought a bold, innovative vision to the University while building meaningful partnerships with business and civic leaders, advancing important industry collaborations and generating the philanthropic support necessary to create new opportunities and lasting impact. Indianapolis is fortunate to have a leader who understands that the success of a university and the success of its community are deeply connected. I am delighted to see her leadership continue at the University of Indianapolis."
Singh assumed the role of UIndy president on July 1, 2023. Before arriving in Indianapolis, she served for three years as provost and senior vice president for academic affairs at Loyola University New Orleans. Previously she spent eleven years at St. Mary's University in San Antonio, Texas, where she was dean of the Greehey School of Business. She also held faculty and leadership roles during 13 years working at Northern Illinois University. She holds a doctorate in business administration from Southern Illinois University, an MBA from Millsaps College and a master's degree in physics from the University of Allahabad in India.
For more information or to arrange an interview, please contact UIndy's Director of Public & Media Relations Dan Klein.
* * *
Original text here: https://news.uindy.edu/2026/11/16/university-of-indianapolis-board-of-trustees-extend-president-tanuja-singhs-contract-through-2031/
* * *
University of Indianapolis Board of Trustees extend President Tanuja Singh's contract through 2031
November 16, 2026
The University of Indianapolis Board of Trustees unanimously approved a new five-year contract for President Tanuja Singh, extending her tenure through 2031. Singh, who became UIndy's 10th president in July 2023, had nearly two years remaining on her current contract.
"The Board of Trustees is extremely pleased to announce the early extension of Dr. Singh's contract," said ... Show Full Article INDIANAPOLIS, Indiana, Nov. 17 -- The University of Indianapolis issued the following news release: * * * University of Indianapolis Board of Trustees extend President Tanuja Singh's contract through 2031 November 16, 2026 The University of Indianapolis Board of Trustees unanimously approved a new five-year contract for President Tanuja Singh, extending her tenure through 2031. Singh, who became UIndy's 10th president in July 2023, had nearly two years remaining on her current contract. "The Board of Trustees is extremely pleased to announce the early extension of Dr. Singh's contract," saidBoard Chair Deborah Daniels. "President Singh has implemented a strategic response at UIndy to the significant challenges facing higher education institutions. Under her leadership, UIndy provides a cost-effective education that prepares its students for successful careers and community leadership. We are confident the university and its students will benefit greatly by her continued service."
"I am very grateful to the Board of Trustees for their continued trust and confidence in my leadership," said Singh. "Over the past three years, we have worked together as a University community to establish a clear vision for UIndy's future and take meaningful steps toward making it happen. I am proud of what we have already accomplished and even more excited about the future. We have an amazing opportunity to build on our momentum, expand our impact and ensure that the University of Indianapolis continues to be a place where students, faculty and staff thrive and are empowered to transform the world around them."
Singh has led a period of strategic growth and innovation at the University of Indianapolis. Among her accomplishments:
* Developed a new strategic plan for UIndy, approved in 2024 by the Board of Trustees, which established a renewed mission and vision for the institution.
* Established UIndy Online, which launched its first three undergraduate programs earlier this year to expand access to affordable and flexible education for nontraditional learners in areas of clear workforce need, including health sciences and elementary education.
* Expanded community partnerships, including an innovative collaboration with Perry Township Schools to bring high school students to the UIndy campus for entrepreneurship education and career-connected learning, as well as career-relevant experiential learning opportunities developed with corporate partners.
* Helped attract significant philanthropic support to strengthen programs across campus, including a $6 million gift to expand the Ron and Laura Strain Honors College, a $5 million gift to establish new programs and help first-generation students in the School of Business and a $2 million gift to establish the R.B. Annis Distinguished Professor of Engineering.
* Spearheaded the creation of the Women's Executive Leadership Institute to provide coaching and executive training to women aspiring to senior leadership roles within their organizations.
"President Singh has made a meaningful impact on our city and region by focusing UIndy's strategy, deepening community partnerships and enhancing outcomes for the university and for Indiana's workforce," said Matt Mindrum, president and CEO of the Indy Chamber. "I'm excited to see what comes next as President Singh continues to serve students and work with the business community to grow the Indy region's economy."
"President Tanuja Singh is an extraordinary leader whose impact reaches far beyond the University of Indianapolis and is helping shape the future of our entire community," said IBJ Media CEO Nate Feltman. "She has brought a bold, innovative vision to the University while building meaningful partnerships with business and civic leaders, advancing important industry collaborations and generating the philanthropic support necessary to create new opportunities and lasting impact. Indianapolis is fortunate to have a leader who understands that the success of a university and the success of its community are deeply connected. I am delighted to see her leadership continue at the University of Indianapolis."
Singh assumed the role of UIndy president on July 1, 2023. Before arriving in Indianapolis, she served for three years as provost and senior vice president for academic affairs at Loyola University New Orleans. Previously she spent eleven years at St. Mary's University in San Antonio, Texas, where she was dean of the Greehey School of Business. She also held faculty and leadership roles during 13 years working at Northern Illinois University. She holds a doctorate in business administration from Southern Illinois University, an MBA from Millsaps College and a master's degree in physics from the University of Allahabad in India.
For more information or to arrange an interview, please contact UIndy's Director of Public & Media Relations Dan Klein.
* * *
Original text here: https://news.uindy.edu/2026/11/16/university-of-indianapolis-board-of-trustees-extend-president-tanuja-singhs-contract-through-2031/
UNM SA+P Professor Receives National Design Studio Grant to Work in Partnership With the Hozho Center in Borrego Pass
ALBUQUERQUE, New Mexico, Nov. 17 -- The University of New Mexico posted the following news:
* * *
UNM SA+P professor receives National Design Studio Grant to work in partnership with the Hozho Center in Borrego Pass
Studio work supports watershed restoration and rainwater harvesting
November 15, 2026
Associate Professor Anthony Fettes of The University of New Mexico School of Architecture + Planning has received an Envision Resilience National Design Studio Grant to fund his graduate-level landscape architecture design studio, Designing for Hozho: Healing Land, Water, and Well-being. The studio ... Show Full Article ALBUQUERQUE, New Mexico, Nov. 17 -- The University of New Mexico posted the following news: * * * UNM SA+P professor receives National Design Studio Grant to work in partnership with the Hozho Center in Borrego Pass Studio work supports watershed restoration and rainwater harvesting November 15, 2026 Associate Professor Anthony Fettes of The University of New Mexico School of Architecture + Planning has received an Envision Resilience National Design Studio Grant to fund his graduate-level landscape architecture design studio, Designing for Hozho: Healing Land, Water, and Well-being. The studiois at work on traditional and regional approaches to address climate challenges and the award will support continued and expanded work into 2027.
The National Design Studio Grant program supports graduate and undergraduate design studios exploring adaptive solutions to climate change in their rural, urban or mid-sized communities. The National Design Studio Grant was created to expand Envision Resilience's mission to advance innovative planning and design in the face of climate change through student and community partnerships.
For 2026, the Indigenous Design Studio returns to the Hozho Voices of Healing Center at Borrego Pass (Dibe Yazhi Habitiin), New Mexico. The initial studio in 2024 established cultural grounding, site understanding and design visioning; this year's studio engages students in hands-on watershed restoration and water-harvesting work that directly addresses real, urgent climate vulnerabilities facing Navajo (Dine) communities.
Grounded in the Dine concept of Hozho - balance, harmony, and beauty, seeking to maintain a positive relationship between each other and the land - the studio is designing and helping to implement demonstration projects featuring passive, Local and Traditional Ecological Knowledge (lo-TEK) water harvesting and land restoration techniques, to support future orchards, gardens and wildlife habitat, while protecting existing historic structures.
"I'm incredibly grateful for the recognition and support to expand the scope of the studio and our continued partnership with the Hozho Center and surrounding communities," said Fettes.
"Our work aligns with that of ecological restoration organizations in our region, centering on time-tested, traditional and hybrid land management practices. Together with our Indigenous community partners, we exchange ideas and practice reciprocity to deepen our connection to place and care for the land, strengthening ecological, social and economic resilience in rural communities in a changing climate," he said.
In addition to the shared benefits of service learning, studio aims to carefully document the process, from cultural learning through construction, to create an illustrated, community-accessible guide to arid land watershed restoration that empowers others in the region to replicate these strategies with minimal resources. In late 2026 and early 2027, this guide is anticipated to expand to on-site workshops, open to those in surrounding communities.
Traditional Ecological Knowledge is the foundation for all design decisions, integrated with contemporary grading, drainage and green infrastructure techniques developed with support from regional experts. For the demonstration projects, students work in small teams, each responsible for a distinct site project, with support from a growing number of partners, including Rio Grande Return - a local non-profit using low-tech and process-based methods to foster resilience, adaptive capacity and stewardship to restore ecosystems in the Southwest.
"The Landscape Architecture Department is grateful for Envision Resilience's recognition of the urgent work our faculty and students are doing weaving Indigenous knowledge and contemporary practice to adapt and mitigate climate change in New Mexico," Catherine Page Harris, Landscape Architecture Department chair, said. "We encourage students to dream big in response to today's challenges."
The studio's long-term goal is to advance the Center's vision for regenerative land management, food sovereignty and wellness, while developing a replicable model for climate-adaptive design in rural Indigenous and arid communities across the American Southwest.
The Indigenous Landscape Studio focuses on community-engaged learning and reciprocity, partnering with nine Dine (Navajo) and Pueblo communities and nonprofits, and is supported by the Indigenous Design and Planning Institute (iD+Pi) at the UNM School of Architecture and Planning. Studios are structured around partnerships, where students engage each community's worldview, culture, and protocols before design work begins and all projects are driven by community-identified needs and aspirations.
To learn more about the Landscape Architecture Department's work, visit landscape.unm.edu.
* * *
Original text here: https://news.unm.edu/news/unm-sa+p-professor-receives-national-design-studio-grant-to-work-in-partnership-with-the-hozho-center-in-borrego-pass
* * *
UNM SA+P professor receives National Design Studio Grant to work in partnership with the Hozho Center in Borrego Pass
Studio work supports watershed restoration and rainwater harvesting
November 15, 2026
Associate Professor Anthony Fettes of The University of New Mexico School of Architecture + Planning has received an Envision Resilience National Design Studio Grant to fund his graduate-level landscape architecture design studio, Designing for Hozho: Healing Land, Water, and Well-being. The studio ... Show Full Article ALBUQUERQUE, New Mexico, Nov. 17 -- The University of New Mexico posted the following news: * * * UNM SA+P professor receives National Design Studio Grant to work in partnership with the Hozho Center in Borrego Pass Studio work supports watershed restoration and rainwater harvesting November 15, 2026 Associate Professor Anthony Fettes of The University of New Mexico School of Architecture + Planning has received an Envision Resilience National Design Studio Grant to fund his graduate-level landscape architecture design studio, Designing for Hozho: Healing Land, Water, and Well-being. The studiois at work on traditional and regional approaches to address climate challenges and the award will support continued and expanded work into 2027.
The National Design Studio Grant program supports graduate and undergraduate design studios exploring adaptive solutions to climate change in their rural, urban or mid-sized communities. The National Design Studio Grant was created to expand Envision Resilience's mission to advance innovative planning and design in the face of climate change through student and community partnerships.
For 2026, the Indigenous Design Studio returns to the Hozho Voices of Healing Center at Borrego Pass (Dibe Yazhi Habitiin), New Mexico. The initial studio in 2024 established cultural grounding, site understanding and design visioning; this year's studio engages students in hands-on watershed restoration and water-harvesting work that directly addresses real, urgent climate vulnerabilities facing Navajo (Dine) communities.
Grounded in the Dine concept of Hozho - balance, harmony, and beauty, seeking to maintain a positive relationship between each other and the land - the studio is designing and helping to implement demonstration projects featuring passive, Local and Traditional Ecological Knowledge (lo-TEK) water harvesting and land restoration techniques, to support future orchards, gardens and wildlife habitat, while protecting existing historic structures.
"I'm incredibly grateful for the recognition and support to expand the scope of the studio and our continued partnership with the Hozho Center and surrounding communities," said Fettes.
"Our work aligns with that of ecological restoration organizations in our region, centering on time-tested, traditional and hybrid land management practices. Together with our Indigenous community partners, we exchange ideas and practice reciprocity to deepen our connection to place and care for the land, strengthening ecological, social and economic resilience in rural communities in a changing climate," he said.
In addition to the shared benefits of service learning, studio aims to carefully document the process, from cultural learning through construction, to create an illustrated, community-accessible guide to arid land watershed restoration that empowers others in the region to replicate these strategies with minimal resources. In late 2026 and early 2027, this guide is anticipated to expand to on-site workshops, open to those in surrounding communities.
Traditional Ecological Knowledge is the foundation for all design decisions, integrated with contemporary grading, drainage and green infrastructure techniques developed with support from regional experts. For the demonstration projects, students work in small teams, each responsible for a distinct site project, with support from a growing number of partners, including Rio Grande Return - a local non-profit using low-tech and process-based methods to foster resilience, adaptive capacity and stewardship to restore ecosystems in the Southwest.
"The Landscape Architecture Department is grateful for Envision Resilience's recognition of the urgent work our faculty and students are doing weaving Indigenous knowledge and contemporary practice to adapt and mitigate climate change in New Mexico," Catherine Page Harris, Landscape Architecture Department chair, said. "We encourage students to dream big in response to today's challenges."
The studio's long-term goal is to advance the Center's vision for regenerative land management, food sovereignty and wellness, while developing a replicable model for climate-adaptive design in rural Indigenous and arid communities across the American Southwest.
The Indigenous Landscape Studio focuses on community-engaged learning and reciprocity, partnering with nine Dine (Navajo) and Pueblo communities and nonprofits, and is supported by the Indigenous Design and Planning Institute (iD+Pi) at the UNM School of Architecture and Planning. Studios are structured around partnerships, where students engage each community's worldview, culture, and protocols before design work begins and all projects are driven by community-identified needs and aspirations.
To learn more about the Landscape Architecture Department's work, visit landscape.unm.edu.
* * *
Original text here: https://news.unm.edu/news/unm-sa+p-professor-receives-national-design-studio-grant-to-work-in-partnership-with-the-hozho-center-in-borrego-pass
U-M Research Explores New Way to Protect Vision From Diabetes-related Damage
ANN ARBOR, Michigan, Nov. 17 (TNSjou) -- The University of Michigan issued the following news:
* * *
U-M research explores new way to protect vision from diabetes-related damage
November 16, 2026
Naturally occurring protein could lead to additional treatment options for diabetic eye disease, a significant concern for India
-
India has more than 100 million people living with diabetes, putting a large population at risk of complications that include vision loss.
Researchers at the University of Michigan are studying a naturally occurring protein that could eventually offer another way to ... Show Full Article ANN ARBOR, Michigan, Nov. 17 (TNSjou) -- The University of Michigan issued the following news: * * * U-M research explores new way to protect vision from diabetes-related damage November 16, 2026 Naturally occurring protein could lead to additional treatment options for diabetic eye disease, a significant concern for India - India has more than 100 million people living with diabetes, putting a large population at risk of complications that include vision loss. Researchers at the University of Michigan are studying a naturally occurring protein that could eventually offer another way toprotect eyesight. They found that the protein, called Norrin, helped reduce blood vessel leakage in the retina, inflammation and nerve cell death. The treatment also preserved vision, including when it was administered after vision had begun to deteriorate.
The findings, published in the journal Diabetes, suggest a different approach to treating diabetic eye disease. While existing treatments primarily block a protein that contributes to blood vessel leakage, David Antonetti, professor of ophthalmology and visual sciences at U-M's Kellogg Eye Center, and collaborators are investigating whether Norrin can help restore the protective barrier that diabetes damages.
The distinction is important, he said, because current treatments do not work equally well for everyone.
Existing therapies target vascular endothelial growth factor, or VEGF, a protein that contributes to abnormal blood vessel growth and leakage in the retina. Drugs that block VEGF have improved treatment for diabetic eye disease, but some patients do not receive the full benefit.
"The big thing is that these therapies block VEGF from causing more damage," Antonetti said. "And what we're looking at here is a factor that's involved in normally creating the proper vascular environment in the retina."
The retina, the light-sensitive tissue at the back of the eye, relies on a protective barrier in its blood vessels to regulate what enters the surrounding tissue. Diabetes can damage this barrier, allowing fluid to leak into the retina. The resulting swelling, known as diabetic macular edema, can affect central vision. Norrin helps form and maintain this barrier. Antonetti and colleagues wanted to find out whether replacing the protein could help repair the damage caused by diabetes.
Their experiments showed that Norrin levels declined in diabetic rats. Supplying the protein helped restore the barrier, reduced inflammation and protected retinal nerve cells from damage.
"So, this factor is down, and we're replacing it," Antonetti said. "There's real hope that since it's a restoring factor and we're losing it ... that we can restore the barrier."
Why the research matters for India
According to the ICMR-INDIAB nationwide study published in The Lancet Diabetes & Endocrinology in 2023, an estimated 101 million people in India were living with diabetes. The study found that 11% of Indian adults had diabetes, while another 15% had prediabetes.
Although not everyone with diabetes develops sight-threatening eye disease, the number of people affected makes finding better ways to prevent and treat diabetic retinopathy especially important. Antonetti cautioned that there is no evidence a Norrin-based treatment would be more effective in India than elsewhere. Its potential lies in providing another option for people who do not get enough benefit from existing treatments.
"The hope is that this can maybe be effective when anti-VEGFs are not," he said.
Whether the approach will help patients who respond poorly to anti-VEGF drugs remains to be determined. But the possibility of another treatment could be particularly meaningful in countries such as India, where diabetes affects millions of people.
From laboratory research to clinical trials
Antonetti said the research into Norrin has also contributed to efforts to develop treatments that work through the same biological pathway. He described collaborations aimed at developing a therapy based on these findings and discussed an investigational drug that has advanced into clinical trials. Rather than supplying Norrin directly, the drug activates the pathway through which Norrin helps maintain the blood-retinal barrier.
Antonetti said a clinical trial had found the investigational treatment to be non-inferior to ranibizumab, an established anti-VEGF drug. That means it met the trial's standard for performing comparably to the existing treatment. He also discussed Merck's involvement in further clinical testing.
Researchers have not yet established whether this approach will work better for patients who respond poorly to anti-VEGF drugs or whether combining the two treatments could provide additional benefits.
Another challenge is how the treatment would reach patients. Antonetti explained that the investigational drug still requires injections into the eye, much like existing therapies. Longer-lasting delivery methods might eventually reduce the need for frequent injections, but those possibilities require further research.
For India, where millions of people with diabetes face the risk of vision loss, the findings offer hope for expanding treatment options. If future studies confirm the benefits of targeting the Norrin pathway, the approach could provide another way to preserve vision, particularly for patients who do not fully benefit from current therapies.
Study: Norrin Treatment Prevents Vascular Permeability and Neural Cell Loss While Preserving Vision in Diabetic Rats (DOI: 10.2337/db26-0340)
* * *
Original text here: https://news.umich.edu/u-m-research-explores-new-way-to-protect-vision-from-diabetes-related-damage/
* * *
U-M research explores new way to protect vision from diabetes-related damage
November 16, 2026
Naturally occurring protein could lead to additional treatment options for diabetic eye disease, a significant concern for India
-
India has more than 100 million people living with diabetes, putting a large population at risk of complications that include vision loss.
Researchers at the University of Michigan are studying a naturally occurring protein that could eventually offer another way to ... Show Full Article ANN ARBOR, Michigan, Nov. 17 (TNSjou) -- The University of Michigan issued the following news: * * * U-M research explores new way to protect vision from diabetes-related damage November 16, 2026 Naturally occurring protein could lead to additional treatment options for diabetic eye disease, a significant concern for India - India has more than 100 million people living with diabetes, putting a large population at risk of complications that include vision loss. Researchers at the University of Michigan are studying a naturally occurring protein that could eventually offer another way toprotect eyesight. They found that the protein, called Norrin, helped reduce blood vessel leakage in the retina, inflammation and nerve cell death. The treatment also preserved vision, including when it was administered after vision had begun to deteriorate.
The findings, published in the journal Diabetes, suggest a different approach to treating diabetic eye disease. While existing treatments primarily block a protein that contributes to blood vessel leakage, David Antonetti, professor of ophthalmology and visual sciences at U-M's Kellogg Eye Center, and collaborators are investigating whether Norrin can help restore the protective barrier that diabetes damages.
The distinction is important, he said, because current treatments do not work equally well for everyone.
Existing therapies target vascular endothelial growth factor, or VEGF, a protein that contributes to abnormal blood vessel growth and leakage in the retina. Drugs that block VEGF have improved treatment for diabetic eye disease, but some patients do not receive the full benefit.
"The big thing is that these therapies block VEGF from causing more damage," Antonetti said. "And what we're looking at here is a factor that's involved in normally creating the proper vascular environment in the retina."
The retina, the light-sensitive tissue at the back of the eye, relies on a protective barrier in its blood vessels to regulate what enters the surrounding tissue. Diabetes can damage this barrier, allowing fluid to leak into the retina. The resulting swelling, known as diabetic macular edema, can affect central vision. Norrin helps form and maintain this barrier. Antonetti and colleagues wanted to find out whether replacing the protein could help repair the damage caused by diabetes.
Their experiments showed that Norrin levels declined in diabetic rats. Supplying the protein helped restore the barrier, reduced inflammation and protected retinal nerve cells from damage.
"So, this factor is down, and we're replacing it," Antonetti said. "There's real hope that since it's a restoring factor and we're losing it ... that we can restore the barrier."
Why the research matters for India
According to the ICMR-INDIAB nationwide study published in The Lancet Diabetes & Endocrinology in 2023, an estimated 101 million people in India were living with diabetes. The study found that 11% of Indian adults had diabetes, while another 15% had prediabetes.
Although not everyone with diabetes develops sight-threatening eye disease, the number of people affected makes finding better ways to prevent and treat diabetic retinopathy especially important. Antonetti cautioned that there is no evidence a Norrin-based treatment would be more effective in India than elsewhere. Its potential lies in providing another option for people who do not get enough benefit from existing treatments.
"The hope is that this can maybe be effective when anti-VEGFs are not," he said.
Whether the approach will help patients who respond poorly to anti-VEGF drugs remains to be determined. But the possibility of another treatment could be particularly meaningful in countries such as India, where diabetes affects millions of people.
From laboratory research to clinical trials
Antonetti said the research into Norrin has also contributed to efforts to develop treatments that work through the same biological pathway. He described collaborations aimed at developing a therapy based on these findings and discussed an investigational drug that has advanced into clinical trials. Rather than supplying Norrin directly, the drug activates the pathway through which Norrin helps maintain the blood-retinal barrier.
Antonetti said a clinical trial had found the investigational treatment to be non-inferior to ranibizumab, an established anti-VEGF drug. That means it met the trial's standard for performing comparably to the existing treatment. He also discussed Merck's involvement in further clinical testing.
Researchers have not yet established whether this approach will work better for patients who respond poorly to anti-VEGF drugs or whether combining the two treatments could provide additional benefits.
Another challenge is how the treatment would reach patients. Antonetti explained that the investigational drug still requires injections into the eye, much like existing therapies. Longer-lasting delivery methods might eventually reduce the need for frequent injections, but those possibilities require further research.
For India, where millions of people with diabetes face the risk of vision loss, the findings offer hope for expanding treatment options. If future studies confirm the benefits of targeting the Norrin pathway, the approach could provide another way to preserve vision, particularly for patients who do not fully benefit from current therapies.
Study: Norrin Treatment Prevents Vascular Permeability and Neural Cell Loss While Preserving Vision in Diabetic Rats (DOI: 10.2337/db26-0340)
* * *
Original text here: https://news.umich.edu/u-m-research-explores-new-way-to-protect-vision-from-diabetes-related-damage/
Sorbonne University: The French and Science - Fifty Years of Research, New Challenges
PARIS, France, Nov. 17 -- Sorbonne University issued the following news:
* * *
The French and Science: fifty years of research, new challenges
How do the French public perceive science today? Has their trust in research changed? What expectations are placed on the scientific community regarding environmental change, the rise of artificial intelligence and the proliferation of disinformation? Furthermore, are there distinct trends in France and do they differ from international perspectives?
16/11/2026
An event on 26 November at the Cordeliers Campus
Launched in 1972, the 'The French and Science' ... Show Full Article PARIS, France, Nov. 17 -- Sorbonne University issued the following news: * * * The French and Science: fifty years of research, new challenges How do the French public perceive science today? Has their trust in research changed? What expectations are placed on the scientific community regarding environmental change, the rise of artificial intelligence and the proliferation of disinformation? Furthermore, are there distinct trends in France and do they differ from international perspectives? 16/11/2026 An event on 26 November at the Cordeliers Campus Launched in 1972, the 'The French and Science'survey has tracked changes in public expectations and attitudes towards research in France for more than fifty years. The study's ninth wave, which has been coordinated by Michel Dubois (GEMASS - CNRS, Sorbonne University) and Daniel Boy (CEVIPOF - Sciences Po), will be presented during a conference held at Sorbonne University's Cordeliers Campus.
Registration for participants from 8.30 am to 9.00 am - Event ends at 5.15 pm
The morning will be devoted to the key findings of the 2026 survey and the trends observed over time. The afternoon will broaden the discussion with an international perspective, culminating in a round-table discussion on the implications of the findings for the relationship between science and society.
Presentations may be carried out in French or English.
Programme
9.00 am - 9.15 am: opening address by Nathalie Drach-Temam, President of Sorbonne University and Udice
9.15 am - 10.00 am: scientific opening address by Gordon Gauchat - University of Wisconsin-Milwaukee (in English)
Gordon Gauchat is an associate professor of sociology at the University of Wisconsin-Milwaukee and a Democracy Visiting Fellow at the Ash Centre at the Harvard Kennedy School. His research focuses on the institutional foundations of scientific legitimacy and their links to democracy. He develops an approach to the public understanding of science that takes into account how citizens perceive and evaluate scientific institutions, going beyond mere indicators of knowledge and trust.
10.00 am - 12.15 pm: Session 1 - The 9th wave of the "The French and Science" survey
Results of the 2026 survey and trends from over more than fifty years
This session will present the main findings of the ninth wave: trust in science, expectations regarding research, and perceptions of its impact on society. It will compare recent changes with long-term trends.
* Daniel Boy - CEVIPOF, Sciences Po
Daniel Boy, Emeritus Research Director at CEVIPOF, has devoted his work to electoral sociology, environmental movements and public attitudes towards scientific and technological development. He has developed several major surveys on perceptions of science and technology in France.
* Martin W. Bauer - London School of Economics and Political Science (LSE)
Professor of Social Psychology and Research Methodology at LSE, Martin W. Bauer studies representations of science and technology from a comparative perspective. Former editor-in-chief of Public Understanding of Science (2009-2016), he co-authored, with Bernard Schiele, AI and Common Sense: Ambitions and Frictions (2024).
* Emiliano Grossman - CEE-CDSP, Sciences Po
Emiliano Grossman is a professor of political science at Sciences Po and director of the Centre for Socio-Political Data (CDSP). He is also affiliated with the Centre for European Studies and Comparative Politics (CEE). His research focuses on agenda setting in public policy, partisan competition and the role of the media.
* Michel Dubois - GEMASS, CNRS/Sorbonne University
A sociologist and research director at the National Centre for Scientific Research (CNRS), Michel Dubois is head of the GEMASS research unit. Since September 2025, he has also been head of the French Office for Research Integrity (Ofis). He coordinated the eighth wave of the survey with Martin W. Bauer and Pauline Hervois, and the ninth most recent wave with Daniel Boy. He recently published, with Catherine Guaspare, Scientific Integrity. A Sociological Study of Good Practices (PUF, 2025).
1.30 pm - 3.30 pm: Session 2 - Attitudes towards science: international perspectives (mainly in English)
National characteristics and common trends
How do the French results compare with surveys conducted in other countries? This session will explore the similarities and differences in attitudes towards science, as well as the role of institutional, political and cultural contexts.
* Fabienne Crettaz von Roten - University of Lausanne
A professor of statistics at the Faculty of Social and Political Sciences at the University of Lausanne, Fabienne Crettaz von Roten studies the relationship between science and society. Her research focuses on public attitudes towards science in Switzerland, particularly animal experimentation, as well as the public engagement of scientists.
* Hans Peter Peters
Hans Peter Peters is editor-in-chief of the journal Public Understanding of Science (SAGE) and associate professor of science journalism at the Free University of Berlin. His research focuses on the role of scientists as communicators to the general public, the relationship between science and the media, the interpretation of media coverage of science, public perceptions of science and technology, and the media portrayal of science.
* Kassandra Thompson, University of Wisconsin-Milwaukee
A PhD student in sociology at the University of Wisconsin-Milwaukee, Kassandra Thompson studies trust in scientific knowledge and the institutional, socio-economic and ethical dimensions of science and technology. Her research focuses in particular on the integration of generative artificial intelligence in research and draws on both quantitative and qualitative methods.
* Simon Fuglsang - Aarhus University
A postdoctoral researcher at the Centre for Studies in Research and Research Policy at Aarhus University, Simon Fuglsang works on the relationship between science and society. His research focuses on public perceptions of science, science communication and research policy.
3.45 pm - 5.05 pm: Session 3 - Round table: what lessons can be learnt for the dialogue between science and society?
Moderator: Benoit Tonson - The Conversation
How can scientific institutions, journalists, science communicators and researchers make use of these findings? This round table will discuss public expectations, the conditions for trust and the forms of dialogue to be developed between science and society.
* Nathalie Drach-Temam - Sorbonne University
Nathalie Drach-Temam is President of Sorbonne University and Udice.
* Alain Fischer - French Academy of Sciences
Alain Fischer is a doctor and professor of paediatric immunology and former director and co-founder of the Imagine Institute for Genetic Diseases at Necker-Enfants Malades Hospital. A member of the French Academy of Sciences, Alain Fischer is also Emeritus Professor at the College de France, holding the Chair of Experimental Medicine, and a member of the US National Academy of Sciences and Medicine.
* Charles Behr - Association of science journalists in news media
Charles Behr is a journalist and producer specialising in science and health. He chairs the AJSPI association, which works to promote the quality of scientific reporting and foster dialogue between journalists and researchers.
* Michele Antoine - Musee des Arts et Metiers, CNAM
Michele Antoine has been director of the Musee des Arts et Metiers since September 2024. A graduate in museology from the University of Montreal, she has curated exhibitions in Quebec and Brussels, and was involved in the creation of the House of European History.
5.05 pm - 5.15 pm: Concluding remarks and closing of the event by Pierre-Marie Chauvin, Vice-president for Arts, Sciences, Culture and Society at Sorbonne University
Scientific committee for the event
* Martin Bauer
* Daniel Boy
* Pierre-Marie Chauvin
* Fabienne Crettaz von Rotten
* Michel Dubois
* Marta Entradas
Marta Entradas is a professor at ISCTE-IUL (Portugal) and a visiting researcher at LSE (United Kingdom). Her research focuses on public opinion regarding science and technology, public trust in science and scientists, and science communication. She obtained her PhD in Science and Technology Studies (STS) from University College London (UCL). She was a Marie Curie (MSCA) fellow at LSE and a Fulbright scholar at Cornell University (New York).
* Pauline Hervois
Pauline Hervois is a demographer. Her work focuses on population quantification and health (disability, disease, infertility) from a historical perspective. She took part in the 2020/2021 'The French and Science' survey.
* * *
Original text here: https://www.sorbonne-universite.fr/en/news/french-and-science-fifty-years-research-new-challenges
* * *
The French and Science: fifty years of research, new challenges
How do the French public perceive science today? Has their trust in research changed? What expectations are placed on the scientific community regarding environmental change, the rise of artificial intelligence and the proliferation of disinformation? Furthermore, are there distinct trends in France and do they differ from international perspectives?
16/11/2026
An event on 26 November at the Cordeliers Campus
Launched in 1972, the 'The French and Science' ... Show Full Article PARIS, France, Nov. 17 -- Sorbonne University issued the following news: * * * The French and Science: fifty years of research, new challenges How do the French public perceive science today? Has their trust in research changed? What expectations are placed on the scientific community regarding environmental change, the rise of artificial intelligence and the proliferation of disinformation? Furthermore, are there distinct trends in France and do they differ from international perspectives? 16/11/2026 An event on 26 November at the Cordeliers Campus Launched in 1972, the 'The French and Science'survey has tracked changes in public expectations and attitudes towards research in France for more than fifty years. The study's ninth wave, which has been coordinated by Michel Dubois (GEMASS - CNRS, Sorbonne University) and Daniel Boy (CEVIPOF - Sciences Po), will be presented during a conference held at Sorbonne University's Cordeliers Campus.
Registration for participants from 8.30 am to 9.00 am - Event ends at 5.15 pm
The morning will be devoted to the key findings of the 2026 survey and the trends observed over time. The afternoon will broaden the discussion with an international perspective, culminating in a round-table discussion on the implications of the findings for the relationship between science and society.
Presentations may be carried out in French or English.
Programme
9.00 am - 9.15 am: opening address by Nathalie Drach-Temam, President of Sorbonne University and Udice
9.15 am - 10.00 am: scientific opening address by Gordon Gauchat - University of Wisconsin-Milwaukee (in English)
Gordon Gauchat is an associate professor of sociology at the University of Wisconsin-Milwaukee and a Democracy Visiting Fellow at the Ash Centre at the Harvard Kennedy School. His research focuses on the institutional foundations of scientific legitimacy and their links to democracy. He develops an approach to the public understanding of science that takes into account how citizens perceive and evaluate scientific institutions, going beyond mere indicators of knowledge and trust.
10.00 am - 12.15 pm: Session 1 - The 9th wave of the "The French and Science" survey
Results of the 2026 survey and trends from over more than fifty years
This session will present the main findings of the ninth wave: trust in science, expectations regarding research, and perceptions of its impact on society. It will compare recent changes with long-term trends.
* Daniel Boy - CEVIPOF, Sciences Po
Daniel Boy, Emeritus Research Director at CEVIPOF, has devoted his work to electoral sociology, environmental movements and public attitudes towards scientific and technological development. He has developed several major surveys on perceptions of science and technology in France.
* Martin W. Bauer - London School of Economics and Political Science (LSE)
Professor of Social Psychology and Research Methodology at LSE, Martin W. Bauer studies representations of science and technology from a comparative perspective. Former editor-in-chief of Public Understanding of Science (2009-2016), he co-authored, with Bernard Schiele, AI and Common Sense: Ambitions and Frictions (2024).
* Emiliano Grossman - CEE-CDSP, Sciences Po
Emiliano Grossman is a professor of political science at Sciences Po and director of the Centre for Socio-Political Data (CDSP). He is also affiliated with the Centre for European Studies and Comparative Politics (CEE). His research focuses on agenda setting in public policy, partisan competition and the role of the media.
* Michel Dubois - GEMASS, CNRS/Sorbonne University
A sociologist and research director at the National Centre for Scientific Research (CNRS), Michel Dubois is head of the GEMASS research unit. Since September 2025, he has also been head of the French Office for Research Integrity (Ofis). He coordinated the eighth wave of the survey with Martin W. Bauer and Pauline Hervois, and the ninth most recent wave with Daniel Boy. He recently published, with Catherine Guaspare, Scientific Integrity. A Sociological Study of Good Practices (PUF, 2025).
1.30 pm - 3.30 pm: Session 2 - Attitudes towards science: international perspectives (mainly in English)
National characteristics and common trends
How do the French results compare with surveys conducted in other countries? This session will explore the similarities and differences in attitudes towards science, as well as the role of institutional, political and cultural contexts.
* Fabienne Crettaz von Roten - University of Lausanne
A professor of statistics at the Faculty of Social and Political Sciences at the University of Lausanne, Fabienne Crettaz von Roten studies the relationship between science and society. Her research focuses on public attitudes towards science in Switzerland, particularly animal experimentation, as well as the public engagement of scientists.
* Hans Peter Peters
Hans Peter Peters is editor-in-chief of the journal Public Understanding of Science (SAGE) and associate professor of science journalism at the Free University of Berlin. His research focuses on the role of scientists as communicators to the general public, the relationship between science and the media, the interpretation of media coverage of science, public perceptions of science and technology, and the media portrayal of science.
* Kassandra Thompson, University of Wisconsin-Milwaukee
A PhD student in sociology at the University of Wisconsin-Milwaukee, Kassandra Thompson studies trust in scientific knowledge and the institutional, socio-economic and ethical dimensions of science and technology. Her research focuses in particular on the integration of generative artificial intelligence in research and draws on both quantitative and qualitative methods.
* Simon Fuglsang - Aarhus University
A postdoctoral researcher at the Centre for Studies in Research and Research Policy at Aarhus University, Simon Fuglsang works on the relationship between science and society. His research focuses on public perceptions of science, science communication and research policy.
3.45 pm - 5.05 pm: Session 3 - Round table: what lessons can be learnt for the dialogue between science and society?
Moderator: Benoit Tonson - The Conversation
How can scientific institutions, journalists, science communicators and researchers make use of these findings? This round table will discuss public expectations, the conditions for trust and the forms of dialogue to be developed between science and society.
* Nathalie Drach-Temam - Sorbonne University
Nathalie Drach-Temam is President of Sorbonne University and Udice.
* Alain Fischer - French Academy of Sciences
Alain Fischer is a doctor and professor of paediatric immunology and former director and co-founder of the Imagine Institute for Genetic Diseases at Necker-Enfants Malades Hospital. A member of the French Academy of Sciences, Alain Fischer is also Emeritus Professor at the College de France, holding the Chair of Experimental Medicine, and a member of the US National Academy of Sciences and Medicine.
* Charles Behr - Association of science journalists in news media
Charles Behr is a journalist and producer specialising in science and health. He chairs the AJSPI association, which works to promote the quality of scientific reporting and foster dialogue between journalists and researchers.
* Michele Antoine - Musee des Arts et Metiers, CNAM
Michele Antoine has been director of the Musee des Arts et Metiers since September 2024. A graduate in museology from the University of Montreal, she has curated exhibitions in Quebec and Brussels, and was involved in the creation of the House of European History.
5.05 pm - 5.15 pm: Concluding remarks and closing of the event by Pierre-Marie Chauvin, Vice-president for Arts, Sciences, Culture and Society at Sorbonne University
Scientific committee for the event
* Martin Bauer
* Daniel Boy
* Pierre-Marie Chauvin
* Fabienne Crettaz von Rotten
* Michel Dubois
* Marta Entradas
Marta Entradas is a professor at ISCTE-IUL (Portugal) and a visiting researcher at LSE (United Kingdom). Her research focuses on public opinion regarding science and technology, public trust in science and scientists, and science communication. She obtained her PhD in Science and Technology Studies (STS) from University College London (UCL). She was a Marie Curie (MSCA) fellow at LSE and a Fulbright scholar at Cornell University (New York).
* Pauline Hervois
Pauline Hervois is a demographer. Her work focuses on population quantification and health (disability, disease, infertility) from a historical perspective. She took part in the 2020/2021 'The French and Science' survey.
* * *
Original text here: https://www.sorbonne-universite.fr/en/news/french-and-science-fifty-years-research-new-challenges
Michigan Medicine: FDA Approved Drug Slows Type 1 Diabetes Progression in 5-year-old Patient
ANN ARBOR, Michigan, Nov. 17 -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
FDA approved drug slows type 1 diabetes progression in 5-year-old patient
Trevor Pilachowski's diabetes risk was diagnosed through TrialNet, an international network dedicated to delaying type 1 diabetes
November 16, 2026
For the first time in 2021, Tara Pilachowski had to confront Type 1 diabetes.
A relative was diagnosed with the disorder.
"It felt like the rug had gotten ripped out from under them," Pilachowski said.
Three years later, ... Show Full Article ANN ARBOR, Michigan, Nov. 17 -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release: * * * FDA approved drug slows type 1 diabetes progression in 5-year-old patient Trevor Pilachowski's diabetes risk was diagnosed through TrialNet, an international network dedicated to delaying type 1 diabetes November 16, 2026 For the first time in 2021, Tara Pilachowski had to confront Type 1 diabetes. A relative was diagnosed with the disorder. "It felt like the rug had gotten ripped out from under them," Pilachowski said. Three years later,her second son, Blake, started showing some symptoms that are commonly associated with the condition, including excessive thirst and urination. Subsequent testing did not reveal any abnormalities.
Concerned by what she had seen with her relative, Pilachowski asked her son's pediatrician Danielle Akers, M.D., for answers.
Akers helped the family get in touch with Inas Thomas, M.D., Clinical Professor of Pediatrics-Endocrinology and member of Caswell Diabetes Institute.
Through Thomas, the Pilachowskis learned about TrialNet, an international network of physicians and scientists dedicated to preventing and delaying the progression of type 1 diabetes.
Thomas is the principal investigator for TrialNet at University of Michigan Health.
TrialNet helps family members get screened if there is a history of type 1 diabetes in their relatives.
When Thomas offered to test Blake, Pilachowski insisted that all her sons get tested.
Quicker diagnosis
Type 1 diabetes is an autoimmune condition where the body's own immune system attacks insulin producing beta cells in the pancreas.
The body then develops antibodies which show the process has started.
TrialNet's screening process helps identify these antibodies quickly and diagnoses individuals before they show any signs of disease.
A few weeks after all three boys had been tested, TrialNet reached out to Pilachowski to discuss the positive test results of her son Trevor.
"At first I thought that there had been a mix up at the lab and they had the wrong kid," Pilachowski said.
"They said that Blake and Grant had tested negative, but Trevor's results were positive."
Blake continued to have negative results for his blood tests. His parents and care team suspect that his symptoms are a part of normal behavior in children who insist on drinking water and going to the bathroom to get out of class to meet their friends.
Pilachowski insisted on a retest for Trevor and in March 2024, his risk for type 1 diabetes was confirmed.
"Once you have two antibodies, you have a 100% chance of developing type 1 diabetes within your lifetime," Thomas said.
"Trevor was positive for all five antibodies we screen for, which puts him at a very high risk of developing type 1 diabetes."
Trevor was classified as being in stage 2 of disease progression since he had abnormal blood glucose levels but was not at the clinical diagnostic level yet.
He has a 75% chance of developing stage 3 diabetes within five years. In stage 3, individuals start showing the symptoms of type 1 diabetes.
Age plays a role in disease progression; younger children progress faster than adults.
Delaying progression
For stage 2 patients who have been diagnosed with an increased risk of type 1 diabetes, U-M Health offers TZIELD infusions.
The drug, which was found to delay the onset of stage 3 diabetes by two years in clinical trials, was previously approved for use by the FDA only for patients age eight and above.
"Although Trevor is likely to develop diabetes at some point in his life, delaying it would be amazing," Thomas said. "Our goal is if we can figure out prevention, we will need to cure less people."
In April 2026, the FDA approved TZIELD's use for children who are one year old and above. Trevor is the first child in Michigan under the age of eight to receive this drug.
Thomas hopes that his early diagnosis, combined with the drug, will help protect his insulin producing cells from dying quickly.
"Although it was scary that he is the youngest at U-M to receive this medication, he is paving the way for other children," Pilachowski said.
"He's still asymptomatic and every day that he is not on insulin is a win for us."
Pilachowski continues to share Trevor's story on her social media channels and has developed a community of people who support each other as their children navigate their experiences with type 1 diabetes.
Trevor continues to lead a typical life for a five-year-old, including playing football, soccer and basketball.
He loves spending time with his brothers and his dog, Bennett.
"Throughout this experience, Trevor never skipped a beat or slowed down," Pilachowski said.
"We are so proud of how wonderful he is growing up to be."
If you have a family member with type 1 diabetes and would like to learn more about TrialNet, email UMHS-Trialnet@med.umich.edu.
* * *
Original text here: https://www.uofmhealth.org/health-lab/fda-approved-drug-slows-type-1-diabetes-progression-5-year-old-patient
* * *
FDA approved drug slows type 1 diabetes progression in 5-year-old patient
Trevor Pilachowski's diabetes risk was diagnosed through TrialNet, an international network dedicated to delaying type 1 diabetes
November 16, 2026
For the first time in 2021, Tara Pilachowski had to confront Type 1 diabetes.
A relative was diagnosed with the disorder.
"It felt like the rug had gotten ripped out from under them," Pilachowski said.
Three years later, ... Show Full Article ANN ARBOR, Michigan, Nov. 17 -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release: * * * FDA approved drug slows type 1 diabetes progression in 5-year-old patient Trevor Pilachowski's diabetes risk was diagnosed through TrialNet, an international network dedicated to delaying type 1 diabetes November 16, 2026 For the first time in 2021, Tara Pilachowski had to confront Type 1 diabetes. A relative was diagnosed with the disorder. "It felt like the rug had gotten ripped out from under them," Pilachowski said. Three years later,her second son, Blake, started showing some symptoms that are commonly associated with the condition, including excessive thirst and urination. Subsequent testing did not reveal any abnormalities.
Concerned by what she had seen with her relative, Pilachowski asked her son's pediatrician Danielle Akers, M.D., for answers.
Akers helped the family get in touch with Inas Thomas, M.D., Clinical Professor of Pediatrics-Endocrinology and member of Caswell Diabetes Institute.
Through Thomas, the Pilachowskis learned about TrialNet, an international network of physicians and scientists dedicated to preventing and delaying the progression of type 1 diabetes.
Thomas is the principal investigator for TrialNet at University of Michigan Health.
TrialNet helps family members get screened if there is a history of type 1 diabetes in their relatives.
When Thomas offered to test Blake, Pilachowski insisted that all her sons get tested.
Quicker diagnosis
Type 1 diabetes is an autoimmune condition where the body's own immune system attacks insulin producing beta cells in the pancreas.
The body then develops antibodies which show the process has started.
TrialNet's screening process helps identify these antibodies quickly and diagnoses individuals before they show any signs of disease.
A few weeks after all three boys had been tested, TrialNet reached out to Pilachowski to discuss the positive test results of her son Trevor.
"At first I thought that there had been a mix up at the lab and they had the wrong kid," Pilachowski said.
"They said that Blake and Grant had tested negative, but Trevor's results were positive."
Blake continued to have negative results for his blood tests. His parents and care team suspect that his symptoms are a part of normal behavior in children who insist on drinking water and going to the bathroom to get out of class to meet their friends.
Pilachowski insisted on a retest for Trevor and in March 2024, his risk for type 1 diabetes was confirmed.
"Once you have two antibodies, you have a 100% chance of developing type 1 diabetes within your lifetime," Thomas said.
"Trevor was positive for all five antibodies we screen for, which puts him at a very high risk of developing type 1 diabetes."
Trevor was classified as being in stage 2 of disease progression since he had abnormal blood glucose levels but was not at the clinical diagnostic level yet.
He has a 75% chance of developing stage 3 diabetes within five years. In stage 3, individuals start showing the symptoms of type 1 diabetes.
Age plays a role in disease progression; younger children progress faster than adults.
Delaying progression
For stage 2 patients who have been diagnosed with an increased risk of type 1 diabetes, U-M Health offers TZIELD infusions.
The drug, which was found to delay the onset of stage 3 diabetes by two years in clinical trials, was previously approved for use by the FDA only for patients age eight and above.
"Although Trevor is likely to develop diabetes at some point in his life, delaying it would be amazing," Thomas said. "Our goal is if we can figure out prevention, we will need to cure less people."
In April 2026, the FDA approved TZIELD's use for children who are one year old and above. Trevor is the first child in Michigan under the age of eight to receive this drug.
Thomas hopes that his early diagnosis, combined with the drug, will help protect his insulin producing cells from dying quickly.
"Although it was scary that he is the youngest at U-M to receive this medication, he is paving the way for other children," Pilachowski said.
"He's still asymptomatic and every day that he is not on insulin is a win for us."
Pilachowski continues to share Trevor's story on her social media channels and has developed a community of people who support each other as their children navigate their experiences with type 1 diabetes.
Trevor continues to lead a typical life for a five-year-old, including playing football, soccer and basketball.
He loves spending time with his brothers and his dog, Bennett.
"Throughout this experience, Trevor never skipped a beat or slowed down," Pilachowski said.
"We are so proud of how wonderful he is growing up to be."
If you have a family member with type 1 diabetes and would like to learn more about TrialNet, email UMHS-Trialnet@med.umich.edu.
* * *
Original text here: https://www.uofmhealth.org/health-lab/fda-approved-drug-slows-type-1-diabetes-progression-5-year-old-patient
